Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma that accounts for approximately 5% of all cases. It is characterized by the presence of large nodules of lymphocytes (B-cells) known as lymphocyte-predominant cells (L’H cells) that are surrounded by smaller T-cells and other cells known as histiocytes.
When NLPHL involves the spleen, it can cause a number of symptoms such as abdominal pain, fatigue, and weight loss. The spleen is an important organ in the immune system that helps to filter blood and fight infections. When it becomes enlarged due to NLPHL, it can lead to complications such as anemia and thrombocytopenia, which can increase the risk of bleeding and infections.
Diagnosing NLPHL involving the spleen can be challenging, as the symptoms can be similar to those of other conditions such as lymphoma, leukemia, and autoimmune disorders. A number of tests may be used to confirm a diagnosis of NLPHL, including blood tests, imaging studies, and a biopsy of the spleen.
Once a diagnosis of NLPHL involving the spleen has been confirmed, a treatment plan can be developed. Treatment options may include chemotherapy, radiation therapy, or a combination of both. Treatment will depend on the stage of the cancer, the size of the tumor, and the overall health of the patient.
In conclusion, NLPHL involving the spleen is a rare subtype of Hodgkin lymphoma that can cause a number of symptoms and complications. Early diagnosis and treatment are important for achieving the best possible outcome.
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma that affects the spleen. It is characterized by the presence of nodules of abnormal lymphocytes that are surrounded by a band of normal cells. The treatment options for this condition depend on the stage and seve...
To see full information about treatment please Sign up or Log in